Accumulation of antibiotics in the environment: Have appropriate measures been taken to protect Canadian human and ecological health?

In Canada, every day, contaminants of emerging concern (CEC) are discharged from waste treatment facilities into freshwaters. CECs such as pharmaceutical active compounds (PhACs), personal care products (PCPs), per- and polyfluoroalkyl substances (PFAS), and microplastics are legally discharged from sewage treatment plants (STPs), water reclamation plants (WRPs), hospital wastewater treatment plants (HWWTPs), or other forms of wastewater treatment facilities (WWTFs). In 2006, the Government of Canada established the Chemicals Management Plan (CMP) to classify chemicals based on a risk-priority assessment, which ranked many CECs such as PhACs as being of low urgency, therefore permitting these substances to continue being released into the environment at unmonitored rates. The problem with ranking PhACs as a low priority is that CMP's risk management assessment overlooks the long-term environmental and synergistic effects of PhAC accumulation, such as the long-term risk of antibiotic CEC accumulation in the spread of antibiotic resistance genes. The goal of this review is to specifically investigate antibiotic CEC accumulation and associated environmental risks to human and environmental health, as well as to determine whether appropriate legislative strategies are in place within Canada's governance framework. In this research, secondary data on antibiotic CEC levels in Canadian and international wastewaters, their potential to promote antibiotic-resistant residues, associated environmental short- and long-term risks, and synergistic effects were all considered. Unlike similar past reviews, this review employed an interdisciplinary approach to propose new strategies from the perspectives of science, engineering, and law.

Impact of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) on secondary sludge microorganisms: removal, potential toxicity, and their implications on existing wastewater treatment regulations in Canada.

Perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) are two of the most commonly researched per- and polyfluoroalkyl substances (PFAS). Globally, many long-chain PFAS compounds including PFOS and PFOA are highly regulated and, in some countries, PFAS use in commercial products is strictly prohibited. Despite the legal regulation of these 'forever chemicals' under the Canadian Environmental Protection Act, PFOA and PFOS compounds are still found in high concentrations in discharges from wastewater treatment plants, both from liquid and sludge streams. Yet, their potential impact on wastewater treatment effectiveness remains poorly understood. The findings of this research show that: (1) PFOS and PFOA might be hindering the overall outcome treatment performance - calling into question the efficacy of Canada's existing wastewater treatment regulatory standard (Wastewater Systems Effluent Regulations, SOR/2012-139), and (2) specific microorganisms from the Thiobacillus and Pseudomonas genera seem capable of adsorbing PFOS and PFOA onto their cell wall and even degrading the chemicals, but it is unclear as to what extent degradation occurs. The results also raise questions whether existing wastewater regulations should be expanded to include the detection and monitoring of PFAS, as well as the establishment of a regulatory wastewater treatment plant discharge standard for PFAS that is protective of human and ecological health.